000 01666 a2200517 4500
005 20250514200127.0
264 0 _c20041102
008 200411s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/sj.bjc.6602146
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAzria, D
245 0 0 _aConcomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients.
_h[electronic resource]
260 _bBritish journal of cancer
_cOct 2004
300 _a1251-60 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents, Hormonal
_xadverse effects
650 0 4 _aApoptosis
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCD4-Positive T-Lymphocytes
650 0 4 _aCD8-Positive T-Lymphocytes
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRadiation Pneumonitis
_xetiology
650 0 4 _aRisk Factors
650 0 4 _aTamoxifen
_xadverse effects
700 1 _aGourgou, S
700 1 _aSozzi, W J
700 1 _aZouhair, A
700 1 _aMirimanoff, R O
700 1 _aKramar, A
700 1 _aLemanski, C
700 1 _aDubois, J B
700 1 _aRomieu, G
700 1 _aPelegrin, A
700 1 _aOzsahin, M
773 0 _tBritish journal of cancer
_gvol. 91
_gno. 7
_gp. 1251-60
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6602146
_zAvailable from publisher's website
999 _c15026314
_d15026314